[
  {
    "ts": null,
    "headline": "Gilead Sciences Inc. stock outperforms competitors despite losses on the day",
    "summary": "Gilead Sciences Inc. stock outperforms competitors despite losses on the day",
    "url": "https://finnhub.io/api/news?id=a765c2c0fbe5189802221407f53e0faa2c0935254d2e989bedd8d55e32f1d98a",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1736181720,
      "headline": "Gilead Sciences Inc. stock outperforms competitors despite losses on the day",
      "id": 132325186,
      "image": "",
      "related": "GILD",
      "source": "MarketWatch",
      "summary": "Gilead Sciences Inc. stock outperforms competitors despite losses on the day",
      "url": "https://finnhub.io/api/news?id=a765c2c0fbe5189802221407f53e0faa2c0935254d2e989bedd8d55e32f1d98a"
    }
  },
  {
    "ts": null,
    "headline": "Here’s Why TCW Relative Value Large Cap Fund Exited its Position in Gilead Sciences (GILD)",
    "summary": "TCW Funds, an investment management company, released its “TCW Relative Value Large Cap Fund” Q3 2024 investor letter. A copy of the letter can be downloaded here. In the third quarter, U.S. and European indices reached all-time highs, fueled by optimism surrounding central bank easing, decreasing inflation, rising hopes for a soft landing, and stimulus […]",
    "url": "https://finnhub.io/api/news?id=e26004ac3201b02d81d8e871576a09e57c322bf7dea761d5f1fc47720705d7ff",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1736175058,
      "headline": "Here’s Why TCW Relative Value Large Cap Fund Exited its Position in Gilead Sciences (GILD)",
      "id": 132287306,
      "image": "https://media.zenfs.com/en/insidermonkey.com/bc0e73782debd64d3c678229ae2b05de",
      "related": "GILD",
      "source": "Yahoo",
      "summary": "TCW Funds, an investment management company, released its “TCW Relative Value Large Cap Fund” Q3 2024 investor letter. A copy of the letter can be downloaded here. In the third quarter, U.S. and European indices reached all-time highs, fueled by optimism surrounding central bank easing, decreasing inflation, rising hopes for a soft landing, and stimulus […]",
      "url": "https://finnhub.io/api/news?id=e26004ac3201b02d81d8e871576a09e57c322bf7dea761d5f1fc47720705d7ff"
    }
  },
  {
    "ts": null,
    "headline": "Gilead Sciences, Inc. (GILD): A Bull Case Theory",
    "summary": "We came across a bullish thesis on Gilead Sciences, Inc. (NASDAQ:GILD) on Substack by Magnus Ofstad. In this article, we will summarize the bulls’ thesis on GILD. Gilead Sciences, Inc. (NASDAQ:GILD)’s share was trading at $91.41 as of Jan 3rd. GILD’s forward P/E was 12.11 according to Yahoo Finance. Gilead Sciences (NASDAQ:GILD) is positioned for significant growth, […]",
    "url": "https://finnhub.io/api/news?id=0f56fc30880b560b02236f73977d77da181d37571170dfa16a8742522c870282",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1736167683,
      "headline": "Gilead Sciences, Inc. (GILD): A Bull Case Theory",
      "id": 132287307,
      "image": "https://media.zenfs.com/en/insidermonkey.com/8a09c4944b2a32058460b34f9c02ab47",
      "related": "GILD",
      "source": "Yahoo",
      "summary": "We came across a bullish thesis on Gilead Sciences, Inc. (NASDAQ:GILD) on Substack by Magnus Ofstad. In this article, we will summarize the bulls’ thesis on GILD. Gilead Sciences, Inc. (NASDAQ:GILD)’s share was trading at $91.41 as of Jan 3rd. GILD’s forward P/E was 12.11 according to Yahoo Finance. Gilead Sciences (NASDAQ:GILD) is positioned for significant growth, […]",
      "url": "https://finnhub.io/api/news?id=0f56fc30880b560b02236f73977d77da181d37571170dfa16a8742522c870282"
    }
  }
]